This topic contains a solution. Click here to go to the answer

Author Question: Explain the difference between an escape contingency and an avoidance contingency. What will be ... (Read 114 times)

armygirl

  • Hero Member
  • *****
  • Posts: 556
Explain the difference between an escape contingency and an avoidance contingency.
 
  What will be an ideal response?

Question 2

Explain how experimental control is demonstrated in a multiple baseline across settings design.
 
  What will be an ideal response?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

steff9894

  • Sr. Member
  • ****
  • Posts: 337
Answer to Question 1

The primary difference between an escape contingency and an avoidance contingency is the presence and absence of the aversive stimulus prior to the occurrence of the response. In an escape contingency, the aversive stimulus is present prior to the response, which terminates the aversive stimulus (thus allowing the person to escape that stimulus). In an avoidance contingency, the aversive stimulus is looming but not present prior to the response. The occurrence of the response prevents the presentation of the aversive stimulus

Answer to Question 2

Answer should include: Experimental control is demonstrated when each behavior is changed when and only when the independent variable is applied to the new setting.




armygirl

  • Member
  • Posts: 556
Reply 2 on: Jun 20, 2018
Excellent


ryhom

  • Member
  • Posts: 366
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Thyroid conditions may make getting pregnant impossible.

Did you know?

In the United States, there is a birth every 8 seconds, according to the U.S. Census Bureau's Population Clock.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

For a complete list of videos, visit our video library